actamericanamrapprovalsaxelsenbayhbigbillbiotechcapitalcareceochallengeschangingchinacompetitioncongresscontrolscurescutsdealdebatedevelopmentdoledrugedgeequityfalloutfdafutureglobalglphealthhealthcareimpactindustryinflationinnovationinsideinstabilityinvestmentinvestorsipjapanjpmkirstenleadershiplifelivemeansmfnnationalnextorphanoutlookpasspatientspharmapoliciespolicypresspricepricingrarereductionreformreshapingreviewrisksbirsciencessecuritysenatorshutdownsignalssmallsolvingsurgetariffstrumpvc